DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles
- PMID: 32543101
- PMCID: PMC7434738
- DOI: 10.1002/mgg3.1362
DMD-related muscular dystrophy in Cameroon: Clinical and genetic profiles
Abstract
Background: Most of the previous studies on Duchenne Muscular Dystrophy (DMD) were conducted in Caucasian, Asian, and Arab populations. Therefore, little is known about the features of this disease in Africans. In this study, we aimed to determine the clinical characteristics of DMD, and the common mutations associated with this condition in a group of Cameroonian patients.
Methods: We recruited DMD patients and performed a general physical examination on each of them. Multiplex ligand-dependant probe amplification was carried out to investigate exon deletions and duplications in the DMD gene (OMIM: 300377) of patients and their mothers.
Results: A total of 17 male patients from 14 families were recruited, aged 14 ± 5.1 (8-23) years. The mean age at onset of symptoms was 4.6 ± 1.5 years, and the mean age at diagnosis was 12.1 ± 5.2 years. Proximal muscle weakness was noted in all patients and calf hypertrophy in the large majority of them (88.2%; 15/17). Flexion contractures were particularly frequent on the ankle (85.7%; 12/14). Wasting of shoulder girdle and thigh muscles was present in 50% (6/12) and 46.2% (6/13) of patients, respectively. No patient presented with hearing impairment. Deletions in DMD gene (OMIM: 300377) occurred in 45.5% of patients (5/11), while duplications were observed in 27.3% (3/11). Both mutation types were clustered between exons 45 and 50, and the proportion of de novo mutation was estimated at 18.2% (2/11).
Conclusion: Despite the first symptoms of DMD occurring in infancy, the diagnosis is frequently made later in adolescence, indicating an underestimation of the number of cases of DMD in Cameroon. Future screening of deletions and duplications in patients from Cameroon should focus on the distal part of the gene.
Keywords: Africa; Cameroon; Duchenne muscular dystrophy; clinical patterns; genetics.
© 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.
Conflict of interest statement
We declare that no competing interests exist.
Figures
References
-
- Aartsma‐Rus, A. , Van Deutekom, J. C. T. , Fokkema, I. F. , Van Ommen, G.‐J.‐B. , & Den Dunnen, J. T. (2006). Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading‐frame rule. Muscle & Nerve, 34(2), 135–144. 10.1002/mus.20586 - DOI - PubMed
-
- Alcántara, M. A. , Villarreal, M. T. , Del Castillo, V. , Gutiérrez, G. , Saldaña, Y. , Maulen, I. , … Orozco, L. (1999). High frequency of de novo deletions in Mexican Duchenne and Becker muscular dystrophy patients. Implications for Genetic Counseling. Clinical Genetics, 55(5), 376–380. 10.1034/j.1399-0004.1999.550514.x - DOI - PubMed
-
- Alvarez Leal, M. , Morales Aguilera, A. , Pérez Zuno, J. A. , Segura Romero, S. , Quiroz Góngora, M. C. , & Paredes García, A. (1994). Relations between delayed diagnosis and forms of onset in Duchenne muscular dystrophy. Gaceta Medica De Mexico, 130(6), 459–464. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
